Key facts
- Notable investors include Shenzhen Capital Group, Detong Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Zhiyanzaowu
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhiyanzaowu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhiyanzaowu
Developer of synthetic biology focusing on artificial intelligence. The company's AI technology drives rational design and catalytic efficiency optimization of key enzymes, providing clients with lower production cost than traditional chemical synthesis.
- Sector
- Healthcare
- HQ
- Shaoxing, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Zhiyanzaowu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhiyanzaowu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhiyanzaowu in its N-PORT filings yet. We sweep new filings monthly.